Paper29907679
The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.
Antony J and 16 others. EMBO Rep, 2018. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer. Papers, record 29907679. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29907679
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.
- PubMed
Topics30
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Adhesion Molecules | Major topic |
| Ovarian Neoplasms | Major topic |
| Proto-Oncogene Proteins | Major topic |
| Receptor Protein-Tyrosine Kinases | Major topic |
| Receptor-Like Protein Tyrosine Phosphatases, Class 5 | Major topic |
| Tumor Suppressor Proteins | Major topic |
| Animals | |
| Benzocycloheptenes | |
| Cell Line, Tumor | |
| Cell Movement | |
| Cell Survival | |
| Chickens | |
| Cholesterol | |
| Enzyme Activation | |
| Epithelial Cells | |
| Fallopian Tubes | |
| Female | |
| GPI-Linked Proteins | |
| Gene Silencing | |
| Humans | |
| Intercellular Signaling Peptides and Proteins | |
| MAP Kinase Signaling System | |
| Membrane Microdomains | |
| Neoplasm Invasiveness | |
| Phosphorylation | |
| Protein Binding | |
| Treatment Outcome | |
| Triazoles | |
| Axl Receptor Tyrosine Kinase | |
| Growth Arrest-Specific Protein 6 |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Cancer Research UK | United Kingdom | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 29967225 | Synergistic inactivation of AXL: a (cross)road to cure ovarian cancer? | https://conductscience.org/library/papers/29967225 |
Source PubMed
References59
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23344542 | Regulatory networks defining EMT during cancer initiation and progression. | Nat Rev Cancer | 2013 | https://conductscience.org/library/papers/23344542 | PubMed |
| 2 | 22432005 | A cell-based small molecule screening method for identifying inhibitors of epithelial-mesenchymal transition in carcinoma. | PLoS One | 2012 | https://conductscience.org/library/papers/22432005 | PubMed |
| 3 | 20543576 | ERK2/Fra1/ZEB pathway induces epithelial-to-mesenchymal transition. | Cell Cycle | 2010 | https://conductscience.org/library/papers/20543576 | PubMed |
| 4 | 18770833 | Detecting protein-protein interactions with CFP-YFP FRET by acceptor photobleaching. | Curr Protoc Cytom | 2006 | https://conductscience.org/library/papers/18770833 | PubMed |
| 5 | 17041095 | Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. | Mol Cancer Ther | 2006 | https://conductscience.org/library/papers/17041095 | PubMed |
| 6 | 23666744 | Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer. | EMBO Mol Med | 2013 | https://conductscience.org/library/papers/23666744 | PubMed |
| 7 | 23567973 | Gas6 induces cancer cell migration and epithelial-mesenchymal transition through upregulation of MAPK and Slug. | Biochem Biophys Res Commun | 2013 | https://conductscience.org/library/papers/23567973 | PubMed |
| 8 | 28401178 | Targeting the AXL signaling pathway in ovarian cancer. | Mol Cell Oncol | 2017 | https://conductscience.org/library/papers/28401178 | PubMed |
| 9 | 20959494 | Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia. | Cancer Res | 2010 | https://conductscience.org/library/papers/20959494 | PubMed |
| 10 | 12892714 | ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. | Cancer Cell | 2003 | https://conductscience.org/library/papers/12892714 | PubMed |
| 11 | 25568918 | The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer. | Nat Rev Cancer | 2014 | https://conductscience.org/library/papers/25568918 | PubMed |
| 12 | 18539112 | Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. | Dev Cell | 2008 | https://conductscience.org/library/papers/18539112 | PubMed |
| 13 | 27703030 | The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer. | Sci Signal | 2016 | https://conductscience.org/library/papers/27703030 | PubMed |
| 14 | 16407160 | Phase coexistence and connectivity in the apical membrane of polarized epithelial cells. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16407160 | PubMed |
| 15 | 20393554 | International network of cancer genome projects. | Nature | 2010 | https://conductscience.org/library/papers/20393554 | PubMed |
| 16 | 18714356 | OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. | PLoS One | 2008 | https://conductscience.org/library/papers/18714356 | PubMed |
| 17 | 24026012 | Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib. | Mol Cancer Ther | 2013 | https://conductscience.org/library/papers/24026012 | PubMed |
| 18 | 17550342 | Function of the zinc-finger transcription factor SNAI2 in cancer and development. | Annu Rev Genet | 2007 | https://conductscience.org/library/papers/17550342 | PubMed |
| 19 | 22841668 | Tumor grafts derived from sarcoma patients retain tumor morphology, viability, and invasion potential and indicate disease outcomes in the chick chorioallantoic membrane model. | Cancer Lett | 2012 | https://conductscience.org/library/papers/22841668 | PubMed |
| 20 | 6766487 | Evaluation of the polyene antibiotic filipin as a cytochemical probe for membrane cholesterol. | J Histochem Cytochem | 1980 | https://conductscience.org/library/papers/6766487 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41991507 | Reprogramming the tumor microenvironment with antibody against membrane-proximal AXL to overcome immune checkpoint blockade resistance. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41991507 | PubMed |
| 41762656 | Lipocalin 2 orchestrates resistance to ferroptosis via AXL. | Cell Rep | 2026 | https://conductscience.org/library/papers/41762656 | PubMed |
| 41561740 | Downregulation of OPCML is associated with activation of AKT signaling and aggressive phenotypes in glioblastoma cells. | Front Oncol | 2025 | https://conductscience.org/library/papers/41561740 | PubMed |
| 40699804 | Bioinformatic RNA-Seq Functional Profiling of the Tumor Suppressor Gene OPCML in Ovarian Cancers: The Multifunctional, Pleiotropic Impacts of Having Three Ig Domains. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699804 | PubMed |
| 38474160 | Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38474160 | PubMed |
| 36193770 | Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling. | Thorac Cancer | 2022 | https://conductscience.org/library/papers/36193770 | PubMed |
| 35582229 | Decoding cancer's camouflage: epithelial-mesenchymal plasticity in resistance to immune checkpoint blockade. | Cancer Drug Resist | 2020 | https://conductscience.org/library/papers/35582229 | PubMed |
| 35572601 | Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition. | Front Immunol | 2022 | https://conductscience.org/library/papers/35572601 | PubMed |
| 35478117 | Combined OPCML and AXL Expression as a Prognostic Marker and OPCML Enhances AXL Inhibitor in Cholangiocarcinoma. | In Vivo | 2022 | https://conductscience.org/library/papers/35478117 | PubMed |
| 35433461 | Integrated Multi-Omics Analysis Identified PTPRG and CHL1 as Key Regulators of Immunophenotypes in Clear Cell Renal Cell Carcinoma(ccRCC). | Front Oncol | 2022 | https://conductscience.org/library/papers/35433461 | PubMed |
| 35071225 | The Role of the Tumor Suppressor Gene Protein Tyrosine Phosphatase Gamma in Cancer. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/35071225 | PubMed |
| 34697068 | OPCML Exerts Antitumor Effects in Cholangiocarcinoma via AXL/STAT3 Inactivation and Rho GTPase Down-regulation. | Cancer Genomics Proteomics | 2021 | https://conductscience.org/library/papers/34697068 | PubMed |
| 34576116 | Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34576116 | PubMed |
| 34277602 | NTNG1 Modulates Cisplatin Resistance in Epithelial Ovarian Cancer Cells via the GAS6/AXL/Akt Pathway. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34277602 | PubMed |
| 33780951 | Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies. | Cells Tissues Organs | 2022 | https://conductscience.org/library/papers/33780951 | PubMed |
| 32895125 | [Luteolin reverses OPCML methylation to inhibit proliferation of breast cancer MDA-MB-231 cells]. | Nan Fang Yi Ke Da Xue Xue Bao | 2020 | https://conductscience.org/library/papers/32895125 | PubMed |
| 32595215 | Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers. | Cancer Gene Ther | 2021 | https://conductscience.org/library/papers/32595215 | PubMed |
| 32298237 | Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib-sensitivity in multiple myeloma via ERK/STAT3 axis. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/32298237 | PubMed |
| 31969654 | Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival. | Sci Rep | 2020 | https://conductscience.org/library/papers/31969654 | PubMed |
| 31959629 | Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer. | J Biol Chem | 2020 | https://conductscience.org/library/papers/31959629 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AXL | 558 | PubTator's text mining | https://conductscience.org/library/genes/558 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| GAS6 | 2621 | PubTator's text mining | https://conductscience.org/library/genes/2621 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| MET | 4233 | PubTator's text mining | https://conductscience.org/library/genes/4233 | NCBI Gene |
| OPCML | 4978 | PubTator's text mining | https://conductscience.org/library/genes/4978 | NCBI Gene |
| PTPRG | 5793 | PubTator's text mining | https://conductscience.org/library/genes/5793 | NCBI Gene |
| SNAI2 | 6591 | PubTator's text mining | https://conductscience.org/library/genes/6591 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29907679
GET https://conductscience.org/api/papers/v1/29907679/references?page=2